# Unicycive Therapeutics, Inc.: Form 8-K, filed May 12, 2026

- Company: [Unicycive Therapeutics, Inc.](/companies/uncy.md) (CIK 1766140)
- Form: 8-K
- Filed: 2026-05-12
- Accepted by EDGAR: May 12, 2026, 07:51 ET
- Period: 2026-05-12
- Accession: 0001213900-26-054736
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1766140/000121390026054736/ea0290277-8k_unicycive.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1766140/000121390026054736/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1766140/000121390026054736/ea0290277-8k_unicycive.htm

Filed May 12, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-054736. Last ingested by Listed: Oct 29, 2026, 16:30 ET. No prices; not investment advice.